| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Granzymes | 40 | 2022 | 271 | 6.230 |
Why?
|
| RNA, Small Interfering | 37 | 2018 | 3505 | 4.640 |
Why?
|
| T-Lymphocytes, Cytotoxic | 43 | 2021 | 1821 | 4.630 |
Why?
|
| Cytotoxicity, Immunologic | 30 | 2021 | 1369 | 4.260 |
Why?
|
| Killer Cells, Natural | 17 | 2024 | 2133 | 3.330 |
Why?
|
| RNA Interference | 29 | 2018 | 2890 | 2.990 |
Why?
|
| Pore Forming Cytotoxic Proteins | 19 | 2022 | 130 | 2.860 |
Why?
|
| MicroRNAs | 29 | 2024 | 3751 | 2.690 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 9 | 2021 | 906 | 2.630 |
Why?
|
| Serine Endopeptidases | 20 | 2006 | 1073 | 2.360 |
Why?
|
| Perforin | 20 | 2018 | 168 | 2.180 |
Why?
|
| Apoptosis | 30 | 2023 | 9724 | 1.980 |
Why?
|
| Phosphate-Binding Proteins | 10 | 2022 | 70 | 1.870 |
Why?
|
| Gene Knockdown Techniques | 11 | 2017 | 1656 | 1.850 |
Why?
|
| Listeria monocytogenes | 10 | 2017 | 250 | 1.840 |
Why?
|
| Inflammasomes | 10 | 2023 | 495 | 1.770 |
Why?
|
| CD8-Positive T-Lymphocytes | 33 | 2021 | 4479 | 1.700 |
Why?
|
| Exodeoxyribonucleases | 7 | 2021 | 180 | 1.600 |
Why?
|
| HIV-1 | 40 | 2018 | 6939 | 1.570 |
Why?
|
| Aptamers, Nucleotide | 5 | 2021 | 166 | 1.500 |
Why?
|
| Trophoblasts | 2 | 2021 | 215 | 1.390 |
Why?
|
| CD4-Positive T-Lymphocytes | 23 | 2018 | 4386 | 1.380 |
Why?
|
| HeLa Cells | 27 | 2020 | 3130 | 1.210 |
Why?
|
| Escherichia coli | 6 | 2020 | 4217 | 1.210 |
Why?
|
| Gene Silencing | 18 | 2015 | 1539 | 1.170 |
Why?
|
| HIV Infections | 42 | 2018 | 16715 | 1.130 |
Why?
|
| Exoribonucleases | 2 | 2018 | 95 | 1.120 |
Why?
|
| Neoplasm Proteins | 8 | 2023 | 3707 | 1.090 |
Why?
|
| Lymphocyte Activation | 23 | 2021 | 5524 | 1.040 |
Why?
|
| Cervix Uteri | 5 | 2018 | 590 | 1.040 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2021 | 520 | 1.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 11 | 2024 | 2916 | 1.030 |
Why?
|
| Phosphoproteins | 10 | 2021 | 2441 | 1.000 |
Why?
|
| Animals | 125 | 2024 | 168768 | 1.000 |
Why?
|
| RNA-Binding Proteins | 6 | 2021 | 1903 | 0.970 |
Why?
|
| RNA, Messenger | 16 | 2018 | 13035 | 0.970 |
Why?
|
| Cell Membrane | 9 | 2023 | 3749 | 0.970 |
Why?
|
| DNA Damage | 11 | 2015 | 2432 | 0.940 |
Why?
|
| Immunological Synapses | 5 | 2023 | 54 | 0.920 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2023 | 27 | 0.910 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2949 | 0.910 |
Why?
|
| Macrophages | 17 | 2022 | 5660 | 0.910 |
Why?
|
| Histones | 7 | 2023 | 2598 | 0.900 |
Why?
|
| Caspase 3 | 4 | 2022 | 758 | 0.870 |
Why?
|
| RNA | 3 | 2018 | 2749 | 0.860 |
Why?
|
| DNA Repair | 9 | 2022 | 2046 | 0.860 |
Why?
|
| Calreticulin | 1 | 2023 | 98 | 0.840 |
Why?
|
| Endosomes | 4 | 2015 | 519 | 0.830 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2022 | 23 | 0.830 |
Why?
|
| Mice | 77 | 2024 | 81201 | 0.830 |
Why?
|
| Caspase 1 | 4 | 2022 | 224 | 0.830 |
Why?
|
| RNA, Neoplasm | 2 | 2015 | 769 | 0.820 |
Why?
|
| Caspases | 10 | 2020 | 928 | 0.810 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2021 | 71 | 0.790 |
Why?
|
| HIV | 9 | 2016 | 1604 | 0.790 |
Why?
|
| Coral Reefs | 1 | 2020 | 19 | 0.770 |
Why?
|
| Secretory Vesicles | 3 | 2014 | 124 | 0.770 |
Why?
|
| K562 Cells | 13 | 2012 | 635 | 0.770 |
Why?
|
| Tombusvirus | 1 | 2020 | 7 | 0.760 |
Why?
|
| RNA Stability | 4 | 2020 | 321 | 0.760 |
Why?
|
| Anthozoa | 1 | 2020 | 62 | 0.730 |
Why?
|
| RNA, Antisense | 2 | 2020 | 138 | 0.720 |
Why?
|
| RNA, Double-Stranded | 2 | 2020 | 290 | 0.720 |
Why?
|
| Membrane Glycoproteins | 16 | 2007 | 3771 | 0.720 |
Why?
|
| Interferon-beta | 2 | 2016 | 324 | 0.710 |
Why?
|
| Genes, gag | 4 | 2011 | 61 | 0.710 |
Why?
|
| Antigens, Protozoan | 2 | 2023 | 322 | 0.690 |
Why?
|
| Receptors, IgG | 2 | 2022 | 582 | 0.690 |
Why?
|
| Cell Nucleus | 7 | 2014 | 2969 | 0.690 |
Why?
|
| HCT116 Cells | 6 | 2022 | 409 | 0.680 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2022 | 8432 | 0.670 |
Why?
|
| Cell Death | 9 | 2021 | 1707 | 0.670 |
Why?
|
| Virus Replication | 18 | 2022 | 2535 | 0.660 |
Why?
|
| Bacteria | 2 | 2020 | 2115 | 0.660 |
Why?
|
| AIDS Vaccines | 9 | 2007 | 938 | 0.650 |
Why?
|
| Monomeric GTP-Binding Proteins | 3 | 2021 | 199 | 0.640 |
Why?
|
| Immunity | 3 | 2021 | 1014 | 0.640 |
Why?
|
| Phagocytosis | 2 | 2021 | 1539 | 0.640 |
Why?
|
| Ribonuclease III | 1 | 2020 | 275 | 0.640 |
Why?
|
| Endocytosis | 4 | 2011 | 985 | 0.630 |
Why?
|
| Cell Line | 29 | 2020 | 16000 | 0.630 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2725 | 0.620 |
Why?
|
| Humans | 200 | 2024 | 744366 | 0.620 |
Why?
|
| Disulfiram | 3 | 2023 | 57 | 0.610 |
Why?
|
| Vagina | 6 | 2017 | 825 | 0.600 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 594 | 0.590 |
Why?
|
| Cytoplasmic Granules | 5 | 2016 | 610 | 0.590 |
Why?
|
| Bacterial Infections | 2 | 2017 | 1401 | 0.590 |
Why?
|
| Base Sequence | 20 | 2022 | 12797 | 0.580 |
Why?
|
| RNA, Untranslated | 4 | 2018 | 453 | 0.580 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2008 | 338 | 0.570 |
Why?
|
| Neoplasms | 14 | 2021 | 21696 | 0.570 |
Why?
|
| 3' Untranslated Regions | 6 | 2018 | 513 | 0.570 |
Why?
|
| HIV Seropositivity | 6 | 2004 | 971 | 0.570 |
Why?
|
| Gene Expression Regulation | 17 | 2020 | 12073 | 0.570 |
Why?
|
| Parasites | 1 | 2019 | 163 | 0.560 |
Why?
|
| Drug Delivery Systems | 7 | 2018 | 2219 | 0.560 |
Why?
|
| Fungi | 1 | 2019 | 327 | 0.560 |
Why?
|
| Malaria, Falciparum | 2 | 2023 | 1077 | 0.540 |
Why?
|
| G-Quadruplexes | 2 | 2015 | 162 | 0.540 |
Why?
|
| Leishmania major | 1 | 2016 | 57 | 0.540 |
Why?
|
| DNA, Viral | 5 | 2012 | 2227 | 0.540 |
Why?
|
| Immunity, Innate | 5 | 2023 | 2962 | 0.530 |
Why?
|
| Host-Pathogen Interactions | 4 | 2022 | 1480 | 0.520 |
Why?
|
| Viruses | 2 | 2014 | 375 | 0.520 |
Why?
|
| Cytotoxicity Tests, Immunologic | 8 | 2005 | 329 | 0.520 |
Why?
|
| Neoplastic Stem Cells | 5 | 2018 | 1376 | 0.510 |
Why?
|
| Virus Diseases | 5 | 2006 | 711 | 0.510 |
Why?
|
| Nucleoside-Diphosphate Kinase | 2 | 2006 | 19 | 0.510 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2190 | 0.510 |
Why?
|
| Mitochondria | 5 | 2018 | 3514 | 0.500 |
Why?
|
| HIV Antigens | 6 | 2004 | 347 | 0.500 |
Why?
|
| Cell Line, Tumor | 19 | 2023 | 16690 | 0.500 |
Why?
|
| Toxoplasma | 1 | 2016 | 150 | 0.500 |
Why?
|
| Molecular Biology | 1 | 2018 | 596 | 0.490 |
Why?
|
| Flow Cytometry | 13 | 2018 | 5974 | 0.490 |
Why?
|
| RNA, Bacterial | 2 | 2013 | 390 | 0.490 |
Why?
|
| Chromatin | 5 | 2023 | 2933 | 0.490 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 590 | 0.490 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 3 | 2009 | 19 | 0.480 |
Why?
|
| Inflammation | 6 | 2022 | 10637 | 0.480 |
Why?
|
| Awards and Prizes | 1 | 2018 | 375 | 0.470 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 197 | 0.460 |
Why?
|
| Receptors, CCR5 | 5 | 2013 | 498 | 0.460 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1888 | 0.460 |
Why?
|
| Cells, Cultured | 21 | 2024 | 19233 | 0.460 |
Why?
|
| Luminescent Proteins | 4 | 2015 | 853 | 0.450 |
Why?
|
| Mentors | 1 | 2018 | 631 | 0.450 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1097 | 0.450 |
Why?
|
| Monocytes | 2 | 2022 | 2596 | 0.450 |
Why?
|
| Signal Transduction | 15 | 2023 | 23404 | 0.450 |
Why?
|
| DNA | 6 | 2014 | 7294 | 0.440 |
Why?
|
| Erythrocytes | 2 | 2021 | 2455 | 0.440 |
Why?
|
| Genes, vif | 2 | 2011 | 17 | 0.420 |
Why?
|
| Cell Movement | 5 | 2020 | 5218 | 0.420 |
Why?
|
| DNA-Binding Proteins | 11 | 2022 | 9647 | 0.410 |
Why?
|
| Plasmodium falciparum | 2 | 2023 | 1732 | 0.410 |
Why?
|
| Liposomes | 6 | 2020 | 759 | 0.410 |
Why?
|
| Interferon-gamma | 9 | 2020 | 3207 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 12 | 2020 | 6386 | 0.400 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2014 | 1837 | 0.400 |
Why?
|
| Antigen-Presenting Cells | 3 | 2017 | 973 | 0.400 |
Why?
|
| Gene Expression | 10 | 2015 | 7798 | 0.400 |
Why?
|
| Cell Fractionation | 2 | 2010 | 252 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1790 | 0.390 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 484 | 0.390 |
Why?
|
| RNA Precursors | 1 | 2012 | 209 | 0.380 |
Why?
|
| Molecular Sequence Data | 17 | 2016 | 18111 | 0.370 |
Why?
|
| Models, Immunological | 4 | 2007 | 527 | 0.370 |
Why?
|
| Cardiolipins | 2 | 2023 | 88 | 0.370 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2010 | 313 | 0.370 |
Why?
|
| Proteins | 7 | 2018 | 6100 | 0.370 |
Why?
|
| Uracil | 1 | 2011 | 165 | 0.360 |
Why?
|
| E2F2 Transcription Factor | 1 | 2009 | 38 | 0.360 |
Why?
|
| Staphylococcus aureus | 2 | 2016 | 1453 | 0.350 |
Why?
|
| Cell Cycle Proteins | 8 | 2016 | 3464 | 0.350 |
Why?
|
| Cell Differentiation | 11 | 2018 | 11486 | 0.340 |
Why?
|
| Genes, cdc | 1 | 2009 | 116 | 0.340 |
Why?
|
| Image Cytometry | 1 | 2009 | 54 | 0.340 |
Why?
|
| Virus Integration | 4 | 2009 | 299 | 0.340 |
Why?
|
| Dynamins | 1 | 2009 | 152 | 0.330 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 436 | 0.330 |
Why?
|
| Mice, SCID | 8 | 2017 | 2716 | 0.330 |
Why?
|
| Antigens, CD | 6 | 2021 | 4026 | 0.330 |
Why?
|
| Herpes Genitalis | 2 | 2009 | 140 | 0.320 |
Why?
|
| Megakaryocytes | 2 | 2009 | 545 | 0.320 |
Why?
|
| Deoxyribonucleases | 4 | 2003 | 214 | 0.320 |
Why?
|
| Clathrin | 1 | 2009 | 267 | 0.320 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2009 | 137 | 0.320 |
Why?
|
| Transplantation Chimera | 1 | 2011 | 613 | 0.320 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2725 | 0.320 |
Why?
|
| Herpesvirus 2, Human | 2 | 2009 | 189 | 0.320 |
Why?
|
| Protein Transport | 6 | 2016 | 1988 | 0.320 |
Why?
|
| HIV Envelope Protein gp160 | 5 | 2011 | 99 | 0.310 |
Why?
|
| G1 Phase | 1 | 2009 | 415 | 0.310 |
Why?
|
| Gene Regulatory Networks | 6 | 2015 | 1707 | 0.310 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2014 | 443 | 0.300 |
Why?
|
| Breast Neoplasms | 8 | 2017 | 20824 | 0.300 |
Why?
|
| HMGB2 Protein | 3 | 2012 | 6 | 0.300 |
Why?
|
| Women | 1 | 2009 | 230 | 0.300 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 440 | 0.300 |
Why?
|
| Jurkat Cells | 6 | 2012 | 743 | 0.300 |
Why?
|
| Immunodominant Epitopes | 3 | 1997 | 267 | 0.290 |
Why?
|
| Immunity, Cellular | 5 | 2014 | 1607 | 0.290 |
Why?
|
| Herpesvirus 4, Human | 4 | 2002 | 1041 | 0.290 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1335 | 0.290 |
Why?
|
| Liver Diseases | 1 | 2015 | 1253 | 0.290 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1677 | 0.290 |
Why?
|
| Sepsis | 2 | 2020 | 2593 | 0.290 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 1832 | 0.290 |
Why?
|
| Stress, Physiological | 2 | 2013 | 1403 | 0.290 |
Why?
|
| Carbon-Oxygen Lyases | 2 | 2003 | 8 | 0.280 |
Why?
|
| Science | 1 | 2009 | 241 | 0.280 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 976 | 0.280 |
Why?
|
| Antigens, Nuclear | 2 | 2007 | 192 | 0.280 |
Why?
|
| Amino Acid Sequence | 15 | 2016 | 13814 | 0.280 |
Why?
|
| Endoplasmic Reticulum | 2 | 2023 | 1146 | 0.270 |
Why?
|
| HEK293 Cells | 7 | 2022 | 4208 | 0.270 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2005 | 735 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3595 | 0.270 |
Why?
|
| Faculty | 1 | 2009 | 387 | 0.270 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 375 | 0.270 |
Why?
|
| Up-Regulation | 6 | 2014 | 4222 | 0.270 |
Why?
|
| Cell Separation | 2 | 2010 | 1751 | 0.270 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 794 | 0.270 |
Why?
|
| Liver | 4 | 2015 | 7475 | 0.260 |
Why?
|
| Immunotherapy | 4 | 2021 | 4446 | 0.260 |
Why?
|
| Alternative Splicing | 2 | 2023 | 1117 | 0.260 |
Why?
|
| Protein Biosynthesis | 3 | 2022 | 2126 | 0.260 |
Why?
|
| Cytokines | 10 | 2023 | 7323 | 0.260 |
Why?
|
| Globins | 1 | 2006 | 416 | 0.260 |
Why?
|
| Cytosol | 5 | 2012 | 901 | 0.250 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2004 | 880 | 0.250 |
Why?
|
| Receptors, KIR | 2 | 2021 | 113 | 0.250 |
Why?
|
| Lymphoma, B-Cell | 3 | 2015 | 931 | 0.250 |
Why?
|
| Multiprotein Complexes | 3 | 2021 | 1120 | 0.250 |
Why?
|
| Cell Proliferation | 9 | 2018 | 10483 | 0.250 |
Why?
|
| Nucleic Acid Conformation | 2 | 2018 | 913 | 0.250 |
Why?
|
| Antigen Presentation | 5 | 2021 | 1284 | 0.240 |
Why?
|
| Peptidylprolyl Isomerase | 2 | 2015 | 105 | 0.240 |
Why?
|
| Protein Binding | 9 | 2018 | 9384 | 0.240 |
Why?
|
| T-Lymphocytes | 11 | 2015 | 10183 | 0.240 |
Why?
|
| Neoplasm Transplantation | 4 | 2015 | 2086 | 0.240 |
Why?
|
| Recombinant Proteins | 12 | 2020 | 6621 | 0.240 |
Why?
|
| Vaccinia virus | 7 | 2005 | 349 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 4 | 2018 | 2700 | 0.240 |
Why?
|
| Renal Circulation | 1 | 2004 | 334 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 988 | 0.230 |
Why?
|
| Substrate Specificity | 6 | 2012 | 1802 | 0.230 |
Why?
|
| Universities | 1 | 2009 | 951 | 0.230 |
Why?
|
| Decidua | 1 | 2024 | 86 | 0.230 |
Why?
|
| Exocytosis | 3 | 2013 | 354 | 0.230 |
Why?
|
| Mice, Nude | 3 | 2022 | 3689 | 0.230 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 3130 | 0.230 |
Why?
|
| Malaria | 3 | 2023 | 1239 | 0.230 |
Why?
|
| Melanoma, Experimental | 2 | 2023 | 561 | 0.230 |
Why?
|
| Receptors, Immunologic | 3 | 2004 | 1423 | 0.220 |
Why?
|
| DNA, Single-Stranded | 2 | 2003 | 355 | 0.220 |
Why?
|
| Gene Products, gag | 5 | 2011 | 337 | 0.220 |
Why?
|
| Neutrophils | 2 | 2023 | 3721 | 0.220 |
Why?
|
| Immune Tolerance | 2 | 2021 | 2259 | 0.220 |
Why?
|
| HLA-A Antigens | 2 | 2003 | 232 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 6 | 2016 | 3848 | 0.220 |
Why?
|
| Gene Targeting | 2 | 2006 | 880 | 0.220 |
Why?
|
| Fusobacterium nucleatum | 1 | 2024 | 163 | 0.210 |
Why?
|
| Female | 38 | 2024 | 380193 | 0.210 |
Why?
|
| HLA-C Antigens | 2 | 2021 | 147 | 0.210 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 70 | 0.210 |
Why?
|
| Tumor Burden | 2 | 2021 | 1915 | 0.210 |
Why?
|
| RNA, Viral | 6 | 2010 | 2901 | 0.210 |
Why?
|
| Genetic Vectors | 5 | 2006 | 3424 | 0.210 |
Why?
|
| Interleukin-1 | 3 | 2022 | 1263 | 0.210 |
Why?
|
| Mice, Transgenic | 9 | 2022 | 9735 | 0.210 |
Why?
|
| Mutation | 10 | 2021 | 29786 | 0.210 |
Why?
|
| Down-Regulation | 7 | 2015 | 3001 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6773 | 0.210 |
Why?
|
| Binding Sites | 7 | 2021 | 6111 | 0.210 |
Why?
|
| Administration, Intravaginal | 4 | 2011 | 150 | 0.200 |
Why?
|
| Placenta | 2 | 2021 | 1699 | 0.200 |
Why?
|
| Plasmids | 4 | 2015 | 2308 | 0.200 |
Why?
|
| Exotoxins | 1 | 2022 | 119 | 0.200 |
Why?
|
| Cell Cycle | 2 | 2009 | 2967 | 0.200 |
Why?
|
| Transcription, Genetic | 5 | 2023 | 7721 | 0.200 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2021 | 27 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2022 | 2540 | 0.200 |
Why?
|
| Rats | 9 | 2020 | 24252 | 0.200 |
Why?
|
| Placentation | 1 | 2021 | 82 | 0.200 |
Why?
|
| DNA Replication | 1 | 2008 | 1399 | 0.200 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2014 | 713 | 0.200 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2003 | 141 | 0.190 |
Why?
|
| Receptors, CCR7 | 2 | 2017 | 108 | 0.190 |
Why?
|
| Caspase 8 | 1 | 2021 | 195 | 0.190 |
Why?
|
| Protein Precursors | 5 | 2021 | 1154 | 0.190 |
Why?
|
| Nucleotides, Cyclic | 1 | 2021 | 81 | 0.190 |
Why?
|
| Hep G2 Cells | 1 | 2022 | 393 | 0.190 |
Why?
|
| 5' Untranslated Regions | 1 | 2022 | 249 | 0.190 |
Why?
|
| Plasmodium yoelii | 1 | 2020 | 39 | 0.190 |
Why?
|
| Lymphocytes | 1 | 2009 | 2617 | 0.190 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2073 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2010 | 3390 | 0.190 |
Why?
|
| Immune System | 2 | 2020 | 806 | 0.190 |
Why?
|
| Myeloid Cells | 1 | 2005 | 810 | 0.180 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2021 | 143 | 0.180 |
Why?
|
| Lysosomes | 2 | 2021 | 893 | 0.180 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2022 | 241 | 0.180 |
Why?
|
| Nuclear Proteins | 6 | 2015 | 5856 | 0.180 |
Why?
|
| Reperfusion Injury | 2 | 2004 | 1026 | 0.180 |
Why?
|
| Cytomegalovirus | 2 | 2002 | 733 | 0.180 |
Why?
|
| Receptors, Chemokine | 2 | 2014 | 670 | 0.180 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2020 | 112 | 0.180 |
Why?
|
| Mice, Inbred NOD | 3 | 2017 | 1879 | 0.180 |
Why?
|
| Histone Chaperones | 4 | 2005 | 76 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2015 | 4554 | 0.180 |
Why?
|
| Interferons | 3 | 2010 | 706 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 21833 | 0.170 |
Why?
|
| Necrosis | 2 | 2020 | 1643 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2022 | 2988 | 0.170 |
Why?
|
| Microscopy, Confocal | 4 | 2016 | 1970 | 0.170 |
Why?
|
| Neoplasm Metastasis | 4 | 2015 | 4851 | 0.170 |
Why?
|
| Reactive Oxygen Species | 5 | 2014 | 2076 | 0.170 |
Why?
|
| Gene Products, env | 4 | 1996 | 263 | 0.170 |
Why?
|
| Epitopes | 3 | 2003 | 2571 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 577 | 0.160 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2018 | 14 | 0.160 |
Why?
|
| Cryoelectron Microscopy | 2 | 2021 | 576 | 0.160 |
Why?
|
| Host-Parasite Interactions | 1 | 2021 | 295 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 2023 | 749 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2022 | 360 | 0.160 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 972 | 0.160 |
Why?
|
| Bacterial Toxins | 2 | 2003 | 931 | 0.160 |
Why?
|
| Transcriptional Activation | 3 | 2015 | 1783 | 0.160 |
Why?
|
| Antigens, Bacterial | 2 | 2003 | 1172 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2004 | 1837 | 0.160 |
Why?
|
| Nanoparticles | 3 | 2020 | 1905 | 0.160 |
Why?
|
| Transfection | 7 | 2016 | 5895 | 0.160 |
Why?
|
| RNA, Small Untranslated | 1 | 2018 | 76 | 0.150 |
Why?
|
| Drug Design | 2 | 2018 | 1076 | 0.150 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1998 | 213 | 0.150 |
Why?
|
| Lymphocyte Count | 4 | 2018 | 793 | 0.150 |
Why?
|
| Cytochromes c | 1 | 2018 | 180 | 0.150 |
Why?
|
| Aspartic Acid | 1 | 2020 | 576 | 0.150 |
Why?
|
| Reticulocytes | 1 | 2018 | 290 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 290 | 0.150 |
Why?
|
| Sialoglycoproteins | 2 | 1995 | 318 | 0.150 |
Why?
|
| Receptor, erbB-2 | 2 | 2021 | 2417 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 2214 | 0.150 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 197 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 2865 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2014 | 1142 | 0.150 |
Why?
|
| Cell Division | 5 | 2011 | 4569 | 0.150 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 174 | 0.150 |
Why?
|
| Proteomics | 5 | 2024 | 3638 | 0.150 |
Why?
|
| Epithelium | 2 | 2014 | 1679 | 0.150 |
Why?
|
| COS Cells | 4 | 2016 | 1161 | 0.140 |
Why?
|
| HIV Core Protein p24 | 4 | 2004 | 256 | 0.140 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2017 | 93 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2023 | 1730 | 0.140 |
Why?
|
| Blood | 1 | 1999 | 598 | 0.140 |
Why?
|
| Complement System Proteins | 1 | 2020 | 795 | 0.140 |
Why?
|
| Lupus Erythematosus, Cutaneous | 2 | 2007 | 58 | 0.140 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2016 | 19 | 0.140 |
Why?
|
| Brazil | 1 | 2021 | 1270 | 0.140 |
Why?
|
| DNA Fragmentation | 3 | 2003 | 242 | 0.140 |
Why?
|
| Plasmodium vivax | 1 | 2018 | 208 | 0.140 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2017 | 122 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 1525 | 0.140 |
Why?
|
| Transcription Factors | 6 | 2008 | 12207 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 4 | 2015 | 1602 | 0.140 |
Why?
|
| Permeability | 1 | 2018 | 738 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2016 | 8436 | 0.140 |
Why?
|
| Streptavidin | 1 | 2016 | 81 | 0.140 |
Why?
|
| Mesoporphyrins | 1 | 2015 | 9 | 0.130 |
Why?
|
| Estrogens | 1 | 2023 | 1566 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2012 | 4162 | 0.130 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2016 | 209 | 0.130 |
Why?
|
| Alcoholism | 2 | 2023 | 1906 | 0.130 |
Why?
|
| Toxoplasmosis | 1 | 2016 | 91 | 0.130 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 898 | 0.130 |
Why?
|
| Membrane Proteins | 4 | 2021 | 7882 | 0.130 |
Why?
|
| Porosity | 1 | 2016 | 362 | 0.130 |
Why?
|
| Didanosine | 3 | 1999 | 153 | 0.130 |
Why?
|
| Protein Phosphatase 2 | 2 | 2008 | 229 | 0.130 |
Why?
|
| Estradiol | 1 | 2023 | 2020 | 0.130 |
Why?
|
| Models, Genetic | 1 | 2006 | 3493 | 0.130 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2015 | 64 | 0.130 |
Why?
|
| Heat-Shock Proteins | 2 | 2002 | 822 | 0.130 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2015 | 246 | 0.130 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 760 | 0.130 |
Why?
|
| Microscopy, Video | 2 | 2016 | 245 | 0.130 |
Why?
|
| HL-60 Cells | 2 | 2009 | 365 | 0.130 |
Why?
|
| U937 Cells | 2 | 2005 | 268 | 0.130 |
Why?
|
| Phosphatidylserines | 1 | 2016 | 193 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2018 | 673 | 0.130 |
Why?
|
| Ribonucleases | 1 | 2016 | 287 | 0.130 |
Why?
|
| Microbial Viability | 1 | 2016 | 234 | 0.130 |
Why?
|
| Biotin | 1 | 2016 | 254 | 0.130 |
Why?
|
| Dynamin II | 1 | 2014 | 35 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2018 | 971 | 0.120 |
Why?
|
| Chimera | 1 | 2016 | 485 | 0.120 |
Why?
|
| Mice, Knockout | 7 | 2023 | 14561 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2016 | 124 | 0.120 |
Why?
|
| Conserved Sequence | 2 | 2016 | 1202 | 0.120 |
Why?
|
| Ribosomes | 1 | 2017 | 500 | 0.120 |
Why?
|
| Clone Cells | 4 | 2017 | 1692 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6171 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 1122 | 0.120 |
Why?
|
| Fetus | 1 | 2021 | 1880 | 0.120 |
Why?
|
| Hydroxyurea | 3 | 1999 | 289 | 0.120 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2014 | 154 | 0.120 |
Why?
|
| Epitope Mapping | 4 | 2003 | 311 | 0.120 |
Why?
|
| Chagas Disease | 1 | 2016 | 166 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 246 | 0.120 |
Why?
|
| Genes, Viral | 2 | 2005 | 718 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2006 | 2232 | 0.120 |
Why?
|
| Ribosomal Proteins | 1 | 2016 | 360 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4253 | 0.120 |
Why?
|
| Interleukin-2 | 5 | 2001 | 1904 | 0.120 |
Why?
|
| Interleukin-12 | 1 | 1996 | 580 | 0.120 |
Why?
|
| B-Lymphocytes | 4 | 2015 | 4666 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2021 | 901 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9445 | 0.110 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2015 | 233 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 2943 | 0.110 |
Why?
|
| Immunophenotyping | 6 | 2017 | 1880 | 0.110 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2013 | 133 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2016 | 449 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2020 | 1375 | 0.110 |
Why?
|
| Dextrans | 1 | 2015 | 595 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 6 | 2014 | 6313 | 0.110 |
Why?
|
| Lamins | 2 | 2003 | 36 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1997 | 1475 | 0.110 |
Why?
|
| Pregnancy | 4 | 2024 | 29144 | 0.110 |
Why?
|
| Nanomedicine | 1 | 2015 | 304 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2646 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2017 | 908 | 0.110 |
Why?
|
| Viral Core Proteins | 1 | 2013 | 162 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2012 | 33 | 0.110 |
Why?
|
| Antibodies | 2 | 2015 | 2460 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2004 | 644 | 0.110 |
Why?
|
| Cytoprotection | 1 | 2013 | 210 | 0.110 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 813 | 0.110 |
Why?
|
| Herpesviridae Infections | 1 | 1994 | 277 | 0.110 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2011 | 127 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2018 | 1534 | 0.110 |
Why?
|
| Trypsin | 2 | 2005 | 511 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 1414 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 808 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 70 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 280 | 0.100 |
Why?
|
| Prognosis | 6 | 2018 | 29060 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2014 | 316 | 0.100 |
Why?
|
| Kinetics | 4 | 2009 | 6476 | 0.100 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2011 | 32 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 135 | 0.100 |
Why?
|
| Ammonium Chloride | 1 | 2011 | 74 | 0.100 |
Why?
|
| Hemophilia A | 1 | 2015 | 351 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2011 | 162 | 0.100 |
Why?
|
| Clonal Anergy | 2 | 2002 | 169 | 0.100 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2011 | 31 | 0.100 |
Why?
|
| Genes, Bacterial | 2 | 2013 | 1079 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2015 | 541 | 0.100 |
Why?
|
| Immunity, Mucosal | 4 | 2014 | 490 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1889 | 0.100 |
Why?
|
| Tumor Virus Infections | 1 | 1994 | 454 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1434 | 0.100 |
Why?
|
| Antiviral Agents | 4 | 2009 | 2987 | 0.090 |
Why?
|
| Gene Products, nef | 3 | 2000 | 110 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2018 | 4010 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2001 | 3702 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2020 | 1723 | 0.090 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2010 | 55 | 0.090 |
Why?
|
| Transaldolase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2018 | 959 | 0.090 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2015 | 428 | 0.090 |
Why?
|
| Polymers | 2 | 2008 | 1621 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2010 | 179 | 0.090 |
Why?
|
| Vaccination | 4 | 2011 | 3279 | 0.090 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2000 | 153 | 0.090 |
Why?
|
| Mutation, Missense | 3 | 2009 | 2566 | 0.090 |
Why?
|
| Cell Survival | 4 | 2018 | 5882 | 0.090 |
Why?
|
| Viral Proteins | 4 | 2005 | 1900 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 508 | 0.090 |
Why?
|
| Macrolides | 1 | 2011 | 201 | 0.090 |
Why?
|
| Receptors, HIV | 2 | 2014 | 163 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2015 | 3144 | 0.090 |
Why?
|
| L-Selectin | 2 | 2001 | 214 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.090 |
Why?
|
| Macromolecular Substances | 2 | 2003 | 1454 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 1572 | 0.090 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2009 | 53 | 0.090 |
Why?
|
| Indinavir | 2 | 1999 | 74 | 0.090 |
Why?
|
| Phorbol Esters | 1 | 2009 | 111 | 0.090 |
Why?
|
| Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2012 | 434 | 0.090 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2009 | 91 | 0.090 |
Why?
|
| Muscle Contraction | 2 | 2011 | 1235 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 560 | 0.090 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2009 | 84 | 0.090 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 2 | 1999 | 112 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2009 | 78 | 0.090 |
Why?
|
| Anti-HIV Agents | 5 | 2008 | 4255 | 0.080 |
Why?
|
| Spodoptera | 2 | 2020 | 153 | 0.080 |
Why?
|
| Virion | 1 | 2011 | 433 | 0.080 |
Why?
|
| Leukemia Virus, Murine | 1 | 2009 | 117 | 0.080 |
Why?
|
| Autoantigens | 2 | 2010 | 892 | 0.080 |
Why?
|
| Nucleosomes | 2 | 2003 | 494 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2649 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2005 | 2850 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2018 | 5451 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2012 | 1683 | 0.080 |
Why?
|
| Uncoupling Agents | 1 | 2008 | 45 | 0.080 |
Why?
|
| Vaccines, Synthetic | 3 | 2004 | 634 | 0.080 |
Why?
|
| NADH Dehydrogenase | 1 | 2008 | 41 | 0.080 |
Why?
|
| Rotenone | 1 | 2008 | 43 | 0.080 |
Why?
|
| Birds | 1 | 2009 | 163 | 0.080 |
Why?
|
| Chronic Disease | 5 | 2004 | 9145 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 498 | 0.080 |
Why?
|
| HIV-2 | 1 | 2009 | 167 | 0.080 |
Why?
|
| Genetic Engineering | 2 | 2006 | 951 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 941 | 0.080 |
Why?
|
| Cell-Free System | 1 | 2008 | 344 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2007 | 3773 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2011 | 645 | 0.080 |
Why?
|
| Boston | 1 | 2021 | 9312 | 0.080 |
Why?
|
| Vaginal Diseases | 1 | 2008 | 102 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 547 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2182 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 1988 | 0.070 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 589 | 0.070 |
Why?
|
| Lipids | 2 | 2015 | 3307 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 659 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2009 | 625 | 0.070 |
Why?
|
| Thrombopoietin | 1 | 2009 | 225 | 0.070 |
Why?
|
| Simian immunodeficiency virus | 2 | 2011 | 846 | 0.070 |
Why?
|
| Polyethyleneimine | 1 | 2007 | 63 | 0.070 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 18034 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2011 | 1101 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
| Blood Cells | 1 | 2009 | 309 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 5 | 1999 | 2560 | 0.070 |
Why?
|
| Carcinogens | 1 | 2009 | 466 | 0.070 |
Why?
|
| Drug Stability | 1 | 2007 | 291 | 0.070 |
Why?
|
| Male | 14 | 2022 | 350115 | 0.070 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 72 | 0.070 |
Why?
|
| Career Mobility | 1 | 2009 | 262 | 0.070 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2008 | 615 | 0.070 |
Why?
|
| Species Specificity | 1 | 2011 | 2478 | 0.070 |
Why?
|
| Plant Viruses | 1 | 2006 | 40 | 0.070 |
Why?
|
| Luciferases, Renilla | 1 | 2006 | 21 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 504 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 15520 | 0.070 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 222 | 0.070 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2004 | 952 | 0.070 |
Why?
|
| Membrane Potentials | 3 | 2005 | 1137 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 2012 | 0.070 |
Why?
|
| Hot Temperature | 2 | 2005 | 1356 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2011 | 1158 | 0.070 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 196 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2917 | 0.070 |
Why?
|
| Immunologic Memory | 3 | 2003 | 1348 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 250 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2008 | 424 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2008 | 404 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3921 | 0.070 |
Why?
|
| Databases, Genetic | 2 | 2010 | 1783 | 0.070 |
Why?
|
| Isoelectric Point | 1 | 2005 | 80 | 0.070 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 379 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2002 | 1536 | 0.070 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2005 | 117 | 0.070 |
Why?
|
| Vaccines, Attenuated | 2 | 2007 | 342 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13693 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1341 | 0.060 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2005 | 76 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1504 | 0.060 |
Why?
|
| Genital Diseases, Female | 1 | 2006 | 197 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 705 | 0.060 |
Why?
|
| Cadherins | 1 | 2009 | 907 | 0.060 |
Why?
|
| Prejudice | 1 | 2009 | 570 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2204 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 7914 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2005 | 203 | 0.060 |
Why?
|
| Blood Urea Nitrogen | 1 | 2004 | 191 | 0.060 |
Why?
|
| Genes, Essential | 1 | 2005 | 183 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1793 | 0.060 |
Why?
|
| Ions | 1 | 2005 | 265 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 2216 | 0.060 |
Why?
|
| Lipoylation | 1 | 2024 | 72 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 4320 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2016 | 5023 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 2 | 1997 | 936 | 0.060 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2023 | 38 | 0.060 |
Why?
|
| Merozoites | 1 | 2023 | 64 | 0.060 |
Why?
|
| Concanavalin A | 1 | 2003 | 191 | 0.060 |
Why?
|
| Disease Transmission, Infectious | 1 | 2009 | 547 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2004 | 708 | 0.060 |
Why?
|
| Adenoviruses, Human | 1 | 2005 | 257 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3646 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2004 | 841 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 686 | 0.050 |
Why?
|
| Time Factors | 4 | 2011 | 40075 | 0.050 |
Why?
|
| Computational Biology | 3 | 2010 | 3519 | 0.050 |
Why?
|
| Genes, nef | 1 | 2002 | 55 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3524 | 0.050 |
Why?
|
| Antibodies, Protozoan | 1 | 2023 | 253 | 0.050 |
Why?
|
| Genes, bcl-2 | 2 | 1999 | 122 | 0.050 |
Why?
|
| Epidermis | 1 | 2005 | 528 | 0.050 |
Why?
|
| Proteome | 1 | 2012 | 1798 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 944 | 0.050 |
Why?
|
| Genome, Human | 1 | 2015 | 4420 | 0.050 |
Why?
|
| Homeostasis | 1 | 2013 | 3339 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2021 | 99 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1547 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 791 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2005 | 435 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 2007 | 0.050 |
Why?
|
| Safety | 2 | 2007 | 1186 | 0.050 |
Why?
|
| Immunization, Secondary | 3 | 2011 | 340 | 0.050 |
Why?
|
| Listeria | 1 | 2000 | 27 | 0.050 |
Why?
|
| North America | 1 | 2004 | 1249 | 0.050 |
Why?
|
| Biotinylation | 1 | 2021 | 179 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2005 | 799 | 0.050 |
Why?
|
| Peptides | 3 | 1998 | 4410 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 485 | 0.050 |
Why?
|
| Viral Load | 4 | 2011 | 3300 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 1794 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2022 | 249 | 0.050 |
Why?
|
| Static Electricity | 1 | 2021 | 263 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2000 | 257 | 0.050 |
Why?
|
| Caspases, Initiator | 1 | 2020 | 32 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2021 | 391 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2000 | 213 | 0.050 |
Why?
|
| Lymphocyte Subsets | 1 | 2001 | 315 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2005 | 1061 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2418 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2021 | 436 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2001 | 682 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 565 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2004 | 841 | 0.040 |
Why?
|
| Autoantibodies | 2 | 2023 | 2036 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 261 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2002 | 403 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 433 | 0.040 |
Why?
|
| HIV Antibodies | 3 | 2007 | 1322 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2022 | 289 | 0.040 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 323 | 0.040 |
Why?
|
| Esterases | 1 | 1999 | 95 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 158 | 0.040 |
Why?
|
| Models, Animal | 1 | 2006 | 2173 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1801 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2005 | 1077 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2000 | 573 | 0.040 |
Why?
|
| China | 1 | 2004 | 2245 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 8949 | 0.040 |
Why?
|
| Gene Library | 1 | 2001 | 1074 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 1998 | 179 | 0.040 |
Why?
|
| Models, Biological | 3 | 2022 | 9584 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13104 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2023 | 714 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 1999 | 186 | 0.040 |
Why?
|
| Alanine | 1 | 2000 | 572 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2022 | 2504 | 0.040 |
Why?
|
| Magnesium | 1 | 2001 | 813 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2020 | 230 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1998 | 189 | 0.040 |
Why?
|
| Baculoviridae | 1 | 1998 | 118 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 2050 | 0.040 |
Why?
|
| Calcium | 2 | 2015 | 5755 | 0.040 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2002 | 570 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2023 | 844 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 1999 | 156 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4933 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2020 | 1225 | 0.040 |
Why?
|
| Bacterial Proteins | 2 | 2022 | 3854 | 0.040 |
Why?
|
| Chemokine CCL19 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2002 | 1124 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 4 | 2007 | 2088 | 0.040 |
Why?
|
| Agranulocytosis | 1 | 1997 | 101 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 323 | 0.040 |
Why?
|
| Chemokine CCL21 | 1 | 2017 | 51 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2000 | 837 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2184 | 0.040 |
Why?
|
| Disease Progression | 4 | 2017 | 13286 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 417 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2018 | 249 | 0.040 |
Why?
|
| Antigens, Viral | 3 | 2011 | 1035 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2000 | 538 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2016 | 20 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 500 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2003 | 1211 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 1887 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3554 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 2017 | 291 | 0.030 |
Why?
|
| Serpins | 1 | 2017 | 247 | 0.030 |
Why?
|
| Cyclins | 1 | 2018 | 603 | 0.030 |
Why?
|
| Enteropeptidase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Interleukins | 1 | 2000 | 791 | 0.030 |
Why?
|
| Herpesviridae | 1 | 1996 | 109 | 0.030 |
Why?
|
| Microspheres | 1 | 1998 | 777 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2005 | 1061 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2000 | 693 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1586 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2016 | 142 | 0.030 |
Why?
|
| Jews | 1 | 1997 | 385 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1998 | 563 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 1872 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1999 | 679 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 3079 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2016 | 287 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1997 | 623 | 0.030 |
Why?
|
| Anticodon | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chromium | 1 | 1995 | 123 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 190 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1996 | 567 | 0.030 |
Why?
|
| Sialic Acids | 1 | 1995 | 128 | 0.030 |
Why?
|
| Axons | 1 | 2023 | 1685 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2018 | 671 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 2751 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 2018 | 707 | 0.030 |
Why?
|
| Phenanthrolines | 1 | 2014 | 55 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1995 | 210 | 0.030 |
Why?
|
| HIV Seronegativity | 1 | 1995 | 211 | 0.030 |
Why?
|
| Protein Folding | 1 | 2018 | 840 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 1622 | 0.030 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 1996 | 314 | 0.030 |
Why?
|
| DNA Primers | 3 | 2008 | 2891 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1995 | 181 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 1996 | 608 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2015 | 549 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2002 | 4328 | 0.030 |
Why?
|
| Microtubule-Organizing Center | 1 | 2013 | 26 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2002 | 21748 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2017 | 607 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 1996 | 844 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 463 | 0.030 |
Why?
|
| Rabbits | 1 | 2000 | 4894 | 0.030 |
Why?
|
| Clozapine | 1 | 1997 | 498 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15535 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 475 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2003 | 5096 | 0.030 |
Why?
|
| Heparin | 1 | 2000 | 1637 | 0.030 |
Why?
|
| Viremia | 2 | 2011 | 736 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1996 | 370 | 0.030 |
Why?
|
| Lung | 2 | 2022 | 9857 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2011 | 2377 | 0.030 |
Why?
|
| Chaperonins | 1 | 2012 | 62 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2012 | 50 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2018 | 878 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2018 | 1382 | 0.030 |
Why?
|
| United States | 3 | 2018 | 69872 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 1265 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1157 | 0.030 |
Why?
|
| Drug Therapy, Combination | 4 | 2008 | 6489 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1994 | 327 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 1170 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2012 | 108 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 4561 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.020 |
Why?
|
| Intestines | 1 | 2000 | 1924 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 934 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2006 | 6542 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1996 | 1189 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1295 | 0.020 |
Why?
|
| Microinjections | 1 | 2011 | 327 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10252 | 0.020 |
Why?
|
| Epigenomics | 1 | 2016 | 903 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2016 | 861 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 141 | 0.020 |
Why?
|
| Mink | 1 | 2009 | 44 | 0.020 |
Why?
|
| Drug Antagonism | 1 | 2009 | 50 | 0.020 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1996 | 1366 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2011 | 1101 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 2 | 1999 | 112 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3873 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 4424 | 0.020 |
Why?
|
| Adult | 7 | 2021 | 214052 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 3037 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 9955 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2009 | 109 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2009 | 251 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 7184 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2045 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1996 | 2383 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 504 | 0.020 |
Why?
|
| Bleomycin | 1 | 2009 | 512 | 0.020 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2008 | 65 | 0.020 |
Why?
|
| Veterans | 1 | 2021 | 2519 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 2003 | 741 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 5181 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2009 | 320 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 1149 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1678 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2008 | 109 | 0.020 |
Why?
|
| HMGA2 Protein | 1 | 2007 | 123 | 0.020 |
Why?
|
| Karyopherins | 1 | 2008 | 137 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 720 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 457 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12356 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 2 | 1999 | 430 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1782 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2010 | 517 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 552 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2007 | 3587 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1995 | 1271 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2004 | 985 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3616 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1994 | 2765 | 0.020 |
Why?
|
| Menopause | 1 | 2014 | 1626 | 0.020 |
Why?
|
| Genes, rev | 1 | 2005 | 13 | 0.020 |
Why?
|
| Primates | 1 | 2008 | 545 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 687 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2007 | 399 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 895 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2005 | 136 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 377 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16367 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2009 | 695 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3590 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2017 | 4397 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1997 | 8319 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2003 | 68 | 0.010 |
Why?
|
| Virus Internalization | 1 | 2008 | 502 | 0.010 |
Why?
|
| Biological Therapy | 1 | 2005 | 138 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1997 | 3057 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 2003 | 128 | 0.010 |
Why?
|
| Thailand | 1 | 2004 | 296 | 0.010 |
Why?
|
| Vaccines, Subunit | 1 | 2003 | 168 | 0.010 |
Why?
|
| Algorithms | 2 | 2010 | 13882 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 63107 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2003 | 258 | 0.010 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2002 | 71 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2002 | 51 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2004 | 221 | 0.010 |
Why?
|
| Peroxidases | 1 | 2002 | 138 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1640 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 4251 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 503 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 2003 | 354 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4285 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 25628 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 1978 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 1418 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 213390 | 0.010 |
Why?
|
| Myelin P2 Protein | 1 | 2000 | 20 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 41005 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2001 | 184 | 0.010 |
Why?
|
| Microcirculation | 1 | 2005 | 1287 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 2804 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2007 | 1692 | 0.010 |
Why?
|
| Zebrafish | 1 | 2011 | 2996 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 3914 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4642 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 216 | 0.010 |
Why?
|
| Chymases | 1 | 1999 | 99 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1999 | 128 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 72296 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 1999 | 193 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2000 | 300 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4185 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1680 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1999 | 455 | 0.010 |
Why?
|
| Tryptases | 1 | 1999 | 190 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2008 | 2684 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 1000 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2000 | 690 | 0.010 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 1799 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8664 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 1899 | 0.010 |
Why?
|
| DNA, Circular | 1 | 1996 | 97 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 1996 | 120 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1995 | 156 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 17446 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1085 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1999 | 2505 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1681 | 0.010 |
Why?
|
| Virus Latency | 1 | 1996 | 358 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2001 | 2266 | 0.010 |
Why?
|
| Proviruses | 1 | 1994 | 318 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77460 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5172 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4459 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12952 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2000 | 1809 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 6933 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 5717 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2256 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1997 | 2421 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 85779 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3203 | 0.010 |
Why?
|
| Europe | 1 | 1997 | 3338 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1999 | 3476 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11366 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14723 | 0.000 |
Why?
|
| Survivors | 1 | 1994 | 2291 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1994 | 3177 | 0.000 |
Why?
|
| Aged | 1 | 2014 | 163288 | 0.000 |
Why?
|